Colored light shone into the eyes for chronic pain and fibromyalgia
Tests different lights shown to the eyes in adults with chronic pain.
Key facts
- Who runs it
- University of North Carolina, Chapel Hill
- Where
- Chapel Hill, United StatesSee the site
- Trial code
- Registry title
- Chromatic Retinal Stimulation to Reduce Chronic Pain and Pain Sensitivity
- Status
- Recruiting
- People taking part
- 20 people, planned
- Started
- 25 Aug 2023
- Expected to end
- 9 Oct 2027
- Type of study
- Interventional, 3 groups
- Treatments tested
- Green Light stimulation
- Equal Energy White stimulation
- S-cone modulating white light
- Record updated
- 2 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with fibromyalgia or chronic low back pain. They will use a portable light device for 2 hours a day for 5 days.
- Age
- 18 to 65 years
- Sex
- All
- Disease stage
- Fibromyalgia or chronic low back pain diagnosed by a doctor. Average pain greater than 4/10 at the start.
Main reasons for not taking part
- Vision disorders causing severe vision loss or blindness
- Color blindness (self-reported)
- Pregnancy
- History of seizure disorder
- Being in prison
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Adults greater than or equal to 18 and less than or equal to 65
- Individuals who have been diagnosed with fibromyalgia or chronic low back pain by their physician
- Individuals who experience an average pain severity greater than 4/10 in intensity at baseline
- Willingness to wear a battery-operated portable ganzfeld light stimulator device for 2 hours per day at the same time each day (ideally complete the light therapy session between 5 am-10 am each morning) for 5 days
- Alert and oriented, and able to provide informed consent
- Ability to read and speak English to complete validated questionnaires
Who cannot take part
- Vision disorders or conditions resulting in severe vision impairment or blindness
- No other history or condition that would, in the investigator's judgment, indicate that the patient would very likely be non-compliant with the study or unsuitable for the study (e.g., might interfere with the study, confound interpretation, or endanger the patient)
- History of seizure disorder
- Individuals with self-report of color blindness
- Prisoner Status
- Pregnancy
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Where in United States
- University of North CarolinaChapel Hill, United StatesContact: Matthew C Mauck, MD PhDTaking people
About the trial
What the trial wants to find out
Participants with chronic pain conditions including chronic low back pain and fibromyalgia may benefit from light stimuli presented to the retina to reduce chronic pain severity and pain sensitivity. Participants will be recruited into this study and will be presented with one of three uniform light stimuli via a wide-field ganzfeld in three conditions to determine the retinal mechanisms that reduce pain. This work will lead to a greater understanding of retinal mechanisms that contribute to pain and will assist the design of future studies to harness the potential of light based pain therapies.
The 3 groups in the trial
- Equal energy white stimulusTreatment being tested
Equal energy white light at 500 lux. The International Commission on Illumination (CIE) coordinates of this light are (x=y=0.33), indicating that the stimulus appears uniformly white which means that the activation of each of the three classes of photoreceptors are equivalent, thus silencing any chromatic opponency. The stimulus will be delivered by a portable battery-operated ganzfeld light stimulation device for 2 hours per day for 5 consecutive days.
Treatment: Equal Energy White stimulation
- Green light stimulusTreatment being tested
Green light at 500 lux. Participants will view 545 nm green light delivered via a portable battery-operated ganzfeld light stimulation device for 2 hours per day for 5 consecutive days.
Treatment: Green Light stimulation
- S-cone modulating white lightTreatment being tested
The S-cone modulating light stimulus will alternate between two light conditions at 500 lux that will activate the S-cones by about 100x differentially between the two conditions while maintaining the L- an M-cones at constant activation between the two alternating conditions using 427 nm versus 545 nm light. The stimulus will be delivered by a portable battery-operated ganzfeld light stimulation device for 2 hours per day for 5 consecutive days.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Chromatic Retinal Stimulation to Reduce Chronic Pain and Pain Sensitivity
- Plain-language title
- Colored light shone into the eyes for chronic pain and fibromyalgiaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT05956067, who can take part
- Record updated
- 2 November 2026